Moderna (MRNA) closed the latest trading day at $41.66, indicating a +0.6% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 1.46%. Elsewhere ...

A scene from the first week of the second Trump administration: After the president held a White House event announcing a ...

“Successful self-replication under no human assistance is the essential step for AI to outsmart [humans], and is an early ...

The measure would seem a premptive strike at a growing industry. No food engineered to include vaccines are approved for use ...

Experts University of British Columbia called for more research on Covid vaccines and heart conditions like myocarditis and ...

The US Department of Health and Human Services awarded Moderna $590 million to continue developing a vaccine to protect against bird flu.

Moderna and Novo Nordisk are once again in the bad books of the U.K.’s drug marketing watchdog. | Moderna and Novo Nordisk ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

"This SPA agreement marks an important milestone in the development of Descartes-08 for MG, providing critical regulatory clarity and a clear path toward potential approval,” said Carsten Brunn, Ph.D.

Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.

Looking to the future, Suven’s Horizon 2 initiative – which includes plans to incorporate capabilities in flow chemistry, ...